Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorSightGlass Vision, Inc.
About this trial
The aim of this study is evaluate and compare the mobility performance of children in daily activities while wearing single vision spectacle lenses (control) versus myopia control spectacle lenses (test).
Eligibility criteria
Qualifiers
Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
Have undergone a self-reported oculo-visual examination within the past two years.
Have no active ocular disease.
Disqualifiers
Have any systemic disease that affects ocular health.
Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine.
Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine.
Trial design
Treatments tested in this trial
- Novel spectacle lens design
- Spectacle lenses
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov